However, in a slightly larger subcohort of ALS patients, Poesen et al. (2017) found increased follow-up CSF NFL levels in a subset of intermediate and fast progressors, while levels were stable in the remaining patients, including those with slow progression. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.